Journal of Oncology

Molecular Imaging in Breast Cancer

Publishing date
02 Nov 2012
Submission deadline
22 Jun 2012

Lead Editor

1Servicio de Medicina Nuclear, Complejo Hospitalario Universitario, Santiago de Compostela, Espana, Spain

2Instituto de Investigación Biomédica, Valencia, Spain

3Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands

4Department of Biochemistry and Organic Chemistry, Uppsala University, Uppsala, Sweden

Molecular Imaging in Breast Cancer


Breast cancer is one of the most frequently diagnosed malignancies and the second leading cause of cancer deaths in American females. Molecular imaging enables visualization of the cellular function and follow-up of molecular process in living organisms. New progresses in molecular imaging technologies are radically changing the ways in which breast cancer is diagnosed and treated resulting in improvement of therapeutic outcome and an increased survival rate for breast cancer victims. Techniques for molecular breast cancer imaging include magnetic resonance imaging (MRI), optical imaging, and radionuclide imaging with positron emission tomography (PET) or single-photon emission-computed tomography (SPECT). Research in molecular imaging is also contributing to our understanding of breast cancer and helping to direct more effective care of patients with breast cancer. There are many new and emerging molecular imaging technologies that can benefit breast cancer patients.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand how molecular imaging helps in breast cancer diagnosis and treatment. We are particularly interested in articles describing the new modalities for molecular imaging, contrast agents, dosimetry, new technological approaches, tools for automatic detection and quantification, and so forth. Potential topics include, but are not limited to:

  • Breast cancer biological parameters useful for imaging
  • Metabolic reprogramming in breast tumor cell as imaging key part
  • Imaging technology underlined breast pathologies: present and future
  • New trends in magnetic resonance breast imaging
  • New trends in ultrasound breast imaging
  • Preclinical imaging as an important tool for breast cancer
  • Contrast agents
  • Dosimetry
  • Radiotracers: present and future
  • Positron emission mammography (PEM)
  • Sentinel node imaging
  • Software imaging management and quantification

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Journal of Oncology
 Journal metrics
Acceptance rate24%
Submission to final decision66 days
Acceptance to publication37 days
Journal Citation Indicator0.680
Impact Factor4.375

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.